Topic specific news, updated constantly
from the most reliable sources, all in one place.


Other NewsOnly
Information Pages

  lupus news only

Syndicate thisRSS FEED


Participate in the LFA's Advocacy Day on Tuesday, March 16 -- from the Comfort ... - ScienceBlog.com (blog)

Participate in the LFA's Advocacy Day on Tuesday, March 16 -- from the Comfort ...
ScienceBlog.com (blog)
Hundreds of advocates from around the country will come together on Capitol Hill to educate Members of Congress about , and encourage them to ...



Piper Jaffray Assumes Coverage on Human Genome Sciences (HGSI) with an ... - StreetInsider.com (subscription)

Piper Jaffray Assumes Coverage on Human Genome Sciences (HGSI) with an ...
StreetInsider.com (subscription)
Our revenue forecast for Benlysta is 10-15% above the Street from 2012-2015, with potential for additional upside dependent on adoption in patients ...



Baker up for another term - Williamsport Sun-Gazette

Baker up for another term
Williamsport Sun-Gazette
He serves on the Firefighters & Emergency Services, Local Tax Reform, and Diabetes and caucuses as well as the Pennsylvania Rural Health Association ...
Baker seeks re-electionTowanda Daily Review

all 2 news articles »


Rheumatoid arthritis treatment suspended - Pharmaceutical Technology Magazine

Rheumatoid arthritis treatment suspended
Pharmaceutical Technology Magazine
The decision follows a recommendation made by the independent Ocrelizumab RA & Data and Safety Monitoring Board based on studies in RA and lupus. ...



Anthem customers in Colorado face higher rates during inquiry - Denver Post

Anthem customers in Colorado face higher rates during inquiry
Denver Post
Laurie Brock, a 60-year-old sufferer, moved to an insurance plan with a higher deductible after Anthem Blue Cross Blue Shield hiked ...

and more »


Psychotherapy Can Help People With Cope - BusinessWeek

Psychotherapy Can Help People With Lupus Cope
BusinessWeek
TUESDAY, March 9 (HealthDay News) -- Psychotherapy helps cut the incidence of psychological woes in patients with who have high levels of daily stress ...

and more »


Investors Unfazed by Roche-Biogen Idec Testing Troubles - Seeking Alpha (blog)

The Hindu

Investors Unfazed by Roche-Biogen Idec Testing Troubles
Seeking Alpha (blog)
PK) and Biogen Idec (BIIB) have suspended phase III trials of ocrelizumab in rheumatoid arthritis (RA) and was the limited impact it had on the shares ...
Roche, Biogen Suffer Setback With Experimental DrugWall Street Journal
The Opportunity That Wasn'tMotley Fool
The TickerBoston Herald
TheStreet.com (subscription) -San Francisco Business Times -Investor's Business Daily
all 214 news articles »